CDKN2B-AS1 and osteosarcoma: To investigate the relationship between ANRIL and chemotherapeutic sensitivity, this study utilized osteosarcoma cell lines to develop ANRIL knockdown and overexpression models to determine the effects on cell viability during cisplatin and doxorubicin treatment.